Better Therapeutics, Inc.

Click Therapeutics, Inc. ’s acquisition of Better Therapeutics, Inc. ’s AspyreRx – the first FDA-authorized prescription digital therapeutic (PDT) for type-2 diabetes – among other assets, reflects t

Given the prevalence of behavioral health issues that often accompany chronic diseases, pairing a pharmacotherapy with a digital therapeutic aimed at driving behavioral change would at first blush see

As the health care transformation is sweeping through health care, the digital therapeutics segment, while promising, has been struggling to distinguish itself from other digital health and wellness p